<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02377128</url>
  </required_header>
  <id_info>
    <org_study_id>0028-15-WOMC</org_study_id>
    <nct_id>NCT02377128</nct_id>
  </id_info>
  <brief_title>Ovarian Reserve Following Bilateral Salpingectomy Versus Tubal Ligation During Cesarean Section</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wolfson Medical Center</source>
  <brief_summary>
    <textblock>
      The aforementioned study was designed to evaluate short term ovarian reserve as assessed by
      anti-Mullerian hormone(AMH) levels following bilateral salpingectomy versus tubal ligation,
      as part of cesarean sections performed in women requesting future sterilization. The
      investigators aim to recruit 3 groups of 15 women undergoing elective cesarean section at the
      investigators' institution, 2 of which request sterilization (allocated to tubal ligation or
      bilateral salpingectomy) and one undergoing solely cesarean section. The groups will have
      blood drawn for AMH prior to the procedure and at a post-operation visit 8 weeks following.
      This is preformed in light of validated data offering better sterilization and possible
      diminished future risk of ovarian cancer with salpingectomy. Also, is has been proved to be
      just as safe as tubal ligation. This will be performed as a randomized controlled trial.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>March 2015</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Anti Mullerian hormone (AMH) levels ng/mL at 8 weeks</measure>
    <time_frame>Baseline and 8 weeks following surgery</time_frame>
    <description>AMH levels</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Ovarian Reserve</condition>
  <arm_group>
    <arm_group_label>Bilateral salpingectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cesarean section with bilateral salpingectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tubal ligation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cesarean section with tubal ligation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Cesarean section with no additional intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral salpingectomy</intervention_name>
    <description>Surgical bilateral removal of fallopian tubes (not involving ovaries)</description>
    <arm_group_label>Bilateral salpingectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tubal ligation</intervention_name>
    <description>Bilateral ligation of fallopian tubes (not involving ovaries)</description>
    <arm_group_label>Tubal ligation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women undergoing elective cesrean section at the investigators' institution,
             requesting sterilization, willing to have blood withdrawn for AMH levels prior to
             surgery, willing to participate in 8 weeks post-operation follow up with blood
             withdrawn

        Exclusion Criteria:

          -  Non-elective cesarean section, non willing to have blood withdrawn or participate in
             follow up, prior salpingectomy, prior premature ovarian failure/egg donation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>McAlpine JN, Hanley GE, Woo MM, Tone AA, Rozenberg N, Swenerton KD, Gilks CB, Finlayson SJ, Huntsman DG, Miller DM; Ovarian Cancer Research Program of British Columbia. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention. Am J Obstet Gynecol. 2014 May;210(5):471.e1-11. doi: 10.1016/j.ajog.2014.01.003. Epub 2014 Jan 9.</citation>
    <PMID>24412119</PMID>
  </reference>
  <reference>
    <citation>Erickson BK, Conner MG, Landen CN Jr. The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol. 2013 Nov;209(5):409-14. doi: 10.1016/j.ajog.2013.04.019. Epub 2013 Apr 10. Review.</citation>
    <PMID>23583217</PMID>
  </reference>
  <reference>
    <citation>Kamran MW, Vaughan D, Crosby D, Wahab NA, Saadeh FA, Gleeson N. Opportunistic and interventional salpingectomy in women at risk: a strategy for preventing pelvic serous cancer (PSC). Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):251-4. doi: 10.1016/j.ejogrb.2013.06.030. Epub 2013 Jul 21.</citation>
    <PMID>23880597</PMID>
  </reference>
  <reference>
    <citation>Rosenblatt KA, Thomas DB. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev. 1996 Nov;5(11):933-5.</citation>
    <PMID>8922304</PMID>
  </reference>
  <reference>
    <citation>Falconer H, Yin L, Grönberg H, Altman D. Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst. 2015 Jan 27;107(2). pii: dju410. doi: 10.1093/jnci/dju410. Print 2015 Feb.</citation>
    <PMID>25628372</PMID>
  </reference>
  <reference>
    <citation>Committee on Gynecologic Practice. Committee opinion no. 620: Salpingectomy for ovarian cancer prevention. Obstet Gynecol. 2015 Jan;125(1):279-81. doi: 10.1097/01.AOG.0000459871.88564.09. Erratum in: Obstet Gynecol. 2016 Feb;127(2):405. Obstet Gynecol. 2016 Feb;127(2):405.</citation>
    <PMID>25560145</PMID>
  </reference>
  <reference>
    <citation>Ghezzi F, Cromi A, Siesto G, Bergamini V, Zefiro F, Bolis P. Infectious morbidity after total laparoscopic hysterectomy: does concomitant salpingectomy make a difference? BJOG. 2009 Mar;116(4):589-93. doi: 10.1111/j.1471-0528.2008.02085.x.</citation>
    <PMID>19250369</PMID>
  </reference>
  <reference>
    <citation>Sezik M, Ozkaya O, Demir F, Sezik HT, Kaya H. Total salpingectomy during abdominal hysterectomy: effects on ovarian reserve and ovarian stromal blood flow. J Obstet Gynaecol Res. 2007 Dec;33(6):863-9.</citation>
    <PMID>18001455</PMID>
  </reference>
  <reference>
    <citation>Morelli M, Venturella R, Mocciaro R, Di Cello A, Rania E, Lico D, D'Alessandro P, Zullo F. Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere. Gynecol Oncol. 2013 Jun;129(3):448-51. doi: 10.1016/j.ygyno.2013.03.023. Epub 2013 Apr 2.</citation>
    <PMID>23558052</PMID>
  </reference>
  <reference>
    <citation>Findley AD, Siedhoff MT, Hobbs KA, Steege JF, Carey ET, McCall CA, Steiner AZ. Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial. Fertil Steril. 2013 Dec;100(6):1704-8. doi: 10.1016/j.fertnstert.2013.07.1997. Epub 2013 Aug 29.</citation>
    <PMID>23993887</PMID>
  </reference>
  <reference>
    <citation>Peterson HB, Xia Z, Hughes JM, Wilcox LS, Tylor LR, Trussell J. The risk of ectopic pregnancy after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group. N Engl J Med. 1997 Mar 13;336(11):762-7.</citation>
    <PMID>9052654</PMID>
  </reference>
  <results_reference>
    <citation>Köninger A, Kauth A, Schmidt B, Schmidt M, Yerlikaya G, Kasimir-Bauer S, Kimmig R, Birdir C. Anti-Mullerian-hormone levels during pregnancy and postpartum. Reprod Biol Endocrinol. 2013 Jul 11;11:60. doi: 10.1186/1477-7827-11-60.</citation>
    <PMID>23844593</PMID>
  </results_reference>
  <results_reference>
    <citation>La Marca A, Giulini S, Orvieto R, De Leo V, Volpe A. Anti-Müllerian hormone concentrations in maternal serum during pregnancy. Hum Reprod. 2005 Jun;20(6):1569-72. Epub 2005 Feb 25.</citation>
    <PMID>15734752</PMID>
  </results_reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2015</study_first_submitted>
  <study_first_submitted_qc>March 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2015</study_first_posted>
  <last_update_submitted>April 28, 2016</last_update_submitted>
  <last_update_submitted_qc>April 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wolfson Medical Center</investigator_affiliation>
    <investigator_full_name>Hadas Ganer Herman</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Study</keyword>
  <keyword>focus</keyword>
  <keyword>ovarian</keyword>
  <keyword>reserve</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

